Source: International Congress 2016 – ILD pathogenesis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Piotr Kopinski (Bydgoszcz, Poland), Piotr Kopinski, Grzegorz Przybylski, Andrzej Dyczek, Ewelina Wedrowska, Joanna Golinska, Adam Szpechcinsk1, Joanna Chorostowska-Wynimko. Studies on apoptosis of alveolar lymphocytes (AL) in exogenous allergic alveolitis (EAA). Eur Respir J 2016; 48: Suppl. 60, 3101

Member's Comments

No comment yet.

Related content which might interest you: Are there differences in the bronchoalveolar lavage (BAL) cytokine profile in children with and without allergic asthma? Source: International Congress 2014 – More paediatric asthma Year: 2014 Studies on bronchoalveolar lavage lymphocytes (L-BAL) apoptosis in pulmonary sarcoidosis (PS) and silicosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003 Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung transplantation Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Alveolar lymphocytes (AL) produce interleukin 27 (IL27), antigen presenting cell-secreted cytokine. Increased expression of IL27 in bronchoalveolar lavage (BAL) of pulmonary sarcoidosis (PS) patients Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis Source: International Congress 2014 – ILDs 5 Year: 2014 Clinical, computed tomography, and cytological peculiarities of different variants of exogenic allergic alveolitis (EAA) Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Elevated Tryptase concentration In bronchoalveolar lavage fluid from patients with chronic eosinophilic pneumonia Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 IL-17A in severe asthma, severe asthma with fungal sensitisation and ABPA Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015 Altered apoptosis in bronchoalveolar lavage lymphocytes after allergen exposure of atopic asthmatic subjects Source: Eur Respir J 2006; 28: 513-522 Year: 2006 Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Alveolar lymphocytes (AL) in healthy individuals are mostly effector T cells. The flow cytometry (FC) lesson for interstitial lung diseases (ILD) evaluation Source: International Congress 2016 – ILD pathogenesis Year: 2016 How to diagnose and manage EAA Source: Annual Congress 2005 - Extrinsic allergic alveolitis Year: 2005 Bronchoalveolar lavage (BAL) in the differential diagnosis of sarcoidosis, extrinsic allergic alveolitis and BOOP Source: Eur Respir J 2003; 22: Suppl. 45, 255s Year: 2003 Interferon gamma (IFNgamma) decreases apoptosis rate of antigen primed T helper lymphocytes from bronchoalveolar lavage (BAL) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Targeting PI3KΔ or JAK in T-cells from COPD and severe asthma subjects reduces corticosteroid insensitive inflammatory responses Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Chemokine concentrations in bronchoalveolar lavage (BAL) in asthma and eosinophilic bronchitis Source: Annual Congress 2004 - Immunology of airway and pulmonary disease Year: 2004